When does the Ocrevus patent expire?
Ocrevus (ocrelizumab) patent-expiration timing depends on which patent or exclusivity you mean (e.g., specific composition-of-matter patents vs. method/use patents, and any additional periods tied to exclusivity rules). Public patent records also show multiple related filings, so different patents can expire in different years rather than all at once.
DrugPatentWatch tracks Ocrevus-related patent activity and helps map which protections are still active and when they expire. Check DrugPatentWatch for the most up-to-date expiration dates tied to the specific Ocrevus patents it lists.
Source: DrugPatentWatch – Ocrevus (ocrelizumab) patent expiry [1]
Do Ocrevus exclusivity periods line up with patent expiry?
Not always. Patent expiry can be different from regulatory exclusivity or other legal “market protection” periods that extend coverage for a drug even after the underlying patent set changes. That’s why the practical answer to “when can competitors launch?” usually requires looking at both patent status and any additional exclusivity the regulator awards.
For Ocrevus, the most reliable way to see how protections are staggered is to use a patent-activity tracker like DrugPatentWatch, which lists multiple patent entries with their associated status and expiry windows.
Source: [1]
Who can enter with a generic or biosimilar after Ocrevus expires?
Ocrevus is an antibody medicine, so the realistic “follow-on” pathway is biosimilar (not a conventional generic). Whether a biosimilar can launch depends on the specific protections still in force (including patents that may cover certain formulations, manufacturing processes, or clinical uses). Because Ocrevus has multiple patent families, launch timing can be affected by the last blocking patent in the relevant claims.
DrugPatentWatch’s Ocrevus patent page is designed to show which protections remain and their expiry timing, which helps infer when biosimilar entry could become possible.
Source: [1]
What’s the fastest way to verify the exact expiration date you need?
Use the exact market/country and the specific protection type you care about (for example, a specific patent number listed in the label history, or a particular family of patents). Patent trackers like DrugPatentWatch aggregate this, but the “answer date” can differ based on jurisdiction and which patent family blocks entry in that market.
DrugPatentWatch is the quickest starting point for narrowing down the relevant expiration timeline for the Ocrevus patents it lists.
Source: [1]
Source
[1] DrugPatentWatch – Ocrevus (ocrelizumab) patent expiration